52-Week efficacy in patients with moderate to severe psoriasis continued on apremilast or switched from etanercept: The LIBERATE study

被引：0
|
作者：
Reich, K. [1 ,2 ]
Papp, K. [3 ]
van de Kerkhof, P. [4 ]
Zhang, Z. [5 ]
Nograles, K. [5 ]
Soung, J. [6 ]
机构：
[1] SCIderm Res Inst, Hamburg, Germany
[2] Dermatol Hamburg, Hamburg, Germany
[3] Prob Med Res, Waterloo, ON, Canada
[4] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands
[5] Celgene Corp, Warren, NJ USA
[6] Southern Calif Dermatol, Santa Ana, CA USA
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：69 / 70
页数：2
相关论文
共 50 条
  • [1] Sustained efficacy of apremilast in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment: 52-week results from the LIBERATE study
    Reich, Kristian
    Soung, Jennifer
    Gooderham, Melinda
    Zhang, Zuoshun
    Nograles, Kristine
    Goodfield, Mark
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB276 - AB276
  • [2] 52-WEEK EFFICACY AND SAFETY OF APREMILAST AND SWITCH FROM ETANERCEPT IN PATIENTS WITH MODERATE TO SEVERE PSORIASIS: RESULTS FROM THE LIBERATE STUDY
    Reich, K.
    Soung, J.
    Gooderham, M.
    Zhang, Z.
    Nograles, K.
    Day, R. M.
    Ferris, L.
    Goodfield, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 349 - 349
  • [3] EFFICACY AND SAFETY OF APREMILAST AND SWITCH FROM ETANERCEPT IN PATIENTS WITH MODERATE TO SEVERE PSORIASIS: 52-WEEK RESULTS FROM THE LIBERATE STUDY
    Reich, K.
    Soung, J.
    Gooderham, M.
    Zhang, Z.
    Nograles, K.
    Day, R. M.
    Ferris, L.
    Goodfield, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 758 - 759
  • [4] Efficacy of apremilast sustained through week 52 in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment: results from the liberate study
    Reich, K.
    Papp, K.
    van de Kerkhof, P.
    Zhang, Z.
    Nograles, K.
    Soung, J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 : 68 - 68
  • [5] Sustained efficacy with apremilast in patients with nail and scalp psoriasis who continued on apremilast or switched from etanercept treatment: 52-week results from the LIBERATE study
    Gooderham, Melinda
    Zhang, Zuoshun
    Day, Robert
    Ferris, Laura
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB277 - AB277
  • [6] Sustained efficacy with apremilast in patients with nail and scalp psoriasis who continued on apremilast or switched from etanercept treatment: 52-week results from the liberate study
    Gooderham, M.
    Zhang, Z.
    Day, R.
    Ferris, L.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 : 66 - 67
  • [7] Efficacy and Safety of Apremilast and Switch from Etanercept in Patients with Moderate to Severe Psoriasis: 52-Week Results
    Reich, Kristian
    Soung, Jennifer
    Gooderham, Melinda
    Zhang, Zuoshun
    Nograles, Kristine
    Day, Robert M.
    Ferris, Laura
    Goodfield, Mark
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [8] LIBERATE trial: sustained efficacy of apremilast in patients with moderate-to-severe psoriasis who continued on apremilast or switched from etanercept treatment
    Reich, K.
    Soung, J.
    Gooderham, M.
    Zhang, Z.
    Nograles, K.
    Goodfield, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 : 71 - 72
  • [9] SAFETY AND EFFICACY OF APREMILAST THROUGH 104 WEEKS IN PATIENTS WITH MODERATE TO SEVERE PSORIASIS WHO CONTINUED ON APREMILAST OR SWITCHED FROM ETANERCEPT TREATMENT IN THE LIBERATE STUDY
    Reich, K.
    Goodfield, M.
    Green, L.
    Nograles, K.
    Chen, R.
    Levi, E.
    Langley, R. G. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1325 - 1326
  • [10] Safety and efficacy of apremilast through 104 weeks in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment in the LIBERATE study
    Reich, Kristian
    Goodfield, Mark
    Green, Lawrence
    Nograles, Kristine
    Chen, Rongdean
    Levi, Eugenia
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB224 - AB224
12345